Form 4 for ENTA ENANTA PHARMACEUTICALS INC
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001062993-22-006708 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-03 | 2022-03-01+ | ENTA | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $43.46 | +36.8K | 47.5K | +346% | +$1.60M |
| DM | 2022-03-03 | 2022-03-01+ | ENTA | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $70.20 | -36.8K | 35.0K | -51% | -$2.58M |
| DM | 2022-03-03 | 2022-03-01+ | ENTA | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $0.00 | -36.8K | 12.5K | -75% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | M | A | 24,339 | $43.46 | 59,321 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-01 | S | D | 24,239 | $70.26 | 35,082 | D | — | — | (F2) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.97, inclusive. |
| 3 | Common | Common Stock | 2022-03-02 | M | A | 12,481 | $43.46 | 47,463 | D | — | — | |
| 4 | Common | Common Stock | 2022-03-01 | S | D | 100 | $71.06 | 34,982 | D | — | — | |
| 5 | Common | Common Stock | 2022-03-02 | S | D | 12,481 | $70.07 | 34,982 | D | — | — | (F3) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.28, inclusive. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-03-02 | M | D | 12,481 | $0.00 | 0 | D | $43.46 · — to 2025-06-29 | 12,481 Common Stock | (F4) 100% of the shares subject to the option are fully vested and exercisable. |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-03-01 | M | D | 24,339 | $0.00 | 12,481 | D | $43.46 · — to 2025-06-29 | 24,339 Common Stock | (F4) 100% of the shares subject to the option are fully vested and exercisable. |